Popov Z, Ivanovski O, Kolevski P, Stankov O, Petrovski D, Cakalaroski K, Ivanovski N
Department of Urology, University Clinical Center-Skopje, Vodnjanska 17, 1000 Skopje, Macedonia.
Transplant Proc. 2007 Oct;39(8):2589-91. doi: 10.1016/j.transproceed.2007.08.022.
The occurrence of malignancies is a well-known serious complication after organ transplantation. Despite the fact that many factors may be involved, the pathogenesis is still unclear. The aim of the present study was to examine the incidence and clinical characteristics of de novo malignancies that arise after renal transplantation over a 13-year experience in a single center in the Balkan Peninsula. During this period, 185 renal transplantations (139 living related and 46 cadaveric) were followed in our department. Overall, 19 malignancies (9.78%) were observed in 15 patients (7.8%). The mean age of these patients was 45 years (range, 21-53 years). Ten patients (55%) developed skin cancers: 8 squamous and 2 basal cell. Kaposi's sarcomas were found in 3 patients (16.6%, 1 visceral form). We also detected 1 breast cancer, 1 seminoma, 1 colon cancer, 1 urogenital-transitional cell-like cancer, 1 renal cell carcinoma, 1 plasmacytoma, and 1 retroperitoneal sarcoma after an ABO incompatible transplantation. All cancers were de novo malignancies that presented at a mean time of 21 months (range, 2-52 months) after surgery. In conclusion, the incidence of malignancy in the present series was similar to that reported elsewhere. The predominance of skin cancers was understandable bearing in mind the sunshine. The appearance of skin malignancies in our group of patients was earlier, more severe, and multiple sites. No cases of posttransplantation lymphoproliferative disorders were observed. Careful clinical examination and long-term screening protocols are needed for early detection and treatment of this life-threatening complication among the transplant population.
恶性肿瘤的发生是器官移植后一种众所周知的严重并发症。尽管可能涉及许多因素,但其发病机制仍不清楚。本研究的目的是在巴尔干半岛一个单一中心13年的经验基础上,研究肾移植后新发恶性肿瘤的发病率和临床特征。在此期间,我们科室对185例肾移植患者(139例亲属活体供肾和46例尸体供肾)进行了随访。总体而言,15例患者(7.8%)中观察到19例恶性肿瘤(9.78%)。这些患者的平均年龄为45岁(范围21 - 53岁)。10例患者(55%)发生皮肤癌:8例鳞状细胞癌和2例基底细胞癌。3例患者(16.6%,1例为内脏型)发现卡波西肉瘤。我们还在1例ABO血型不相容移植后检测到1例乳腺癌、1例精原细胞瘤、1例结肠癌、1例泌尿生殖系统移行细胞样癌、1例肾细胞癌、1例浆细胞瘤和1例腹膜后肉瘤。所有癌症均为新发恶性肿瘤,术后平均出现时间为21个月(范围2 - 52个月)。总之,本系列中恶性肿瘤的发病率与其他地方报道的相似。考虑到阳光照射,皮肤癌占优势是可以理解的。我们这组患者中皮肤恶性肿瘤的出现更早、更严重且为多部位。未观察到移植后淋巴细胞增生性疾病病例。对于移植人群中这种危及生命的并发症,需要进行仔细的临床检查和长期筛查方案以早期发现和治疗。